LRMR
LRMR
US5171251003
Larimar Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
277.37M EUR
316.84M EUR
467.47M EUR
316.57M EUR
Enterprise Value
130.52M EUR
229.11M EUR
293.34M EUR
235.23M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2.52x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.19x
2.49x
2.96x
4.05x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.73x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-33.95%
-49.26%
-28.09%
-27.39%
ende